<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The Mix1 homeobox-like (MIXL1) gene encodes a paired class homeobox transcription factor that is involved in embryogenesis </plain></SENT>
<SENT sid="1" pm="."><plain>Previous studies have shown that the MIXL1 gene product is expressed in B- and T-cell progenitors of <z:mpath ids='MPATH_458'>normal</z:mpath> bone marrow and, in some cell lines derived from hematopoietic <z:hpo ids='HP_0002664'>neoplasms</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The status of MIXL1 expression and subcellular localization in human <z:hpo ids='HP_0002665'>lymphomas</z:hpo> is unknown </plain></SENT>
<SENT sid="3" pm="."><plain>Using a highly specific antibody, we assessed for MIXL1 expression in <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell lines of B- and T-cell lineage by reverse transcriptase-polymerase chain reaction, Western blot analysis, and immunohistochemistry </plain></SENT>
<SENT sid="4" pm="."><plain>We also assessed for MIXL1 expression using immunohistochemical methods in 193 <z:mp ids='MP_0002022'>lymphoid tumors</z:mp>, including 140 B-cell non-Hodgkin <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (NHL), 36 T-cell NHL, and 17 Hodgkin <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (<z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>) </plain></SENT>
<SENT sid="5" pm="."><plain>MIXL1 was detected predominantly in the nuclear fraction of <z:hpo ids='HP_0000001'>all</z:hpo> cell lines tested and was predominantly nuclear in <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e> specimens </plain></SENT>
<SENT sid="6" pm="."><plain>Based on the distribution of the staining results (histogram), a 50% cutoff was selected for high versus low MIXL1 expression </plain></SENT>
<SENT sid="7" pm="."><plain>High MIXL1 expression was detected more frequently in Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> compared with other types of B-cell NHL (P &lt; .0001, chi(2) test) </plain></SENT>
<SENT sid="8" pm="."><plain>Most cases of T-cell NHL and <z:hpo ids='HP_0000001'>all</z:hpo> cases of <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> also highly expressed MIXL1 </plain></SENT>
<SENT sid="9" pm="."><plain>Most plasma cell <z:mp ids='MP_0009440'>myelomas</z:mp> were negative for MIXL1, but rare cases had low MIXL1 expression </plain></SENT>
<SENT sid="10" pm="."><plain>MIXL1 expression significantly correlated with proliferation index (Ki-67) in B-cell NHL (P &lt; .0001) </plain></SENT>
<SENT sid="11" pm="."><plain>The frequent and high expression of MIXL1 in aggressive B-cell NHL, T-cell NHL, and <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> suggests that MIXL1 may be involved in <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">lymphomagenesis</z:e> </plain></SENT>
</text></document>